LITTLE FALLS, N.J.,
Dec. 19, 2018 /PRNewswire/
-- Cantel Medical Corp. (NYSE: CMD) announced
today that its Board of Directors approved an increase in its
semiannual cash dividend from $0.085
to $0.10 per outstanding share of the
Company's Common Stock. The dividend is payable on January 31, 2019 to shareholders of record at the
close of business on January 17,
2019.
"We are pleased to announce the increase in our dividend, which
will raise our annual payment from $0.17 to $0.20 per
share. This is the 9th consecutive year that we have
increased our dividend. The 17.6% increase is a direct result of
record sales and strong earnings performance and demonstrates our
confidence in the future success of Cantel," stated Charles M. Diker, Chairman of the Board. "We
remain committed to enhancing value for our shareholders and the
dividend is an important component."
About Cantel
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention products and services
for patients, caregivers, and other healthcare providers which
improve outcomes, enhance safety and help save lives. Our
products include specialized medical device reprocessing systems
for endoscopy and renal dialysis, advanced water purification
equipment, sterilants, disinfectants and cleaners, sterility
assurance monitoring products for hospitals and dental clinics,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates, hollow fiber membrane
filtration and separation products. Additionally, we provide
technical service for our products.
For further information, visit the Cantel website
at www.cantelmedical.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-medical-announces-17-6-increase-in-semiannual-dividend-300768942.html
SOURCE Cantel Medical Corp.